Erratum: Expression of concern (Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease (2008) 48(5) (1292–1300), (S0741521408010112), (10.1016/j.jvs.2008.06.041));Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease

Journal of Vascular Surgery

Volumn 48, Issue 5, 2008, Pages 1292-1300

  Bitto, Alessandra ^a   Polito, Francesca ^a   Altavilla, Domenica ^a   Minutoli, Letteria ^a   Migliorato, Alba ^b   Squadrito, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; POLYDEOXYRIBONUCLEOTIDE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; HISTOLOGY; LIMB ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 55049118817     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2022.06.085     Document Type: Erratum

References (28)

1. Dormandy J., Heeck L., and Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 12 (1999) 123-137
2. Gillum R.F. Peripheral arterial occlusive disease of the extremities in the United States: hospitalization and mortality. Am Heart J 120 (1990) 1414-1418
3. Garcia L.A. Epidemiology and pathophysiology of lower extremity peripheral arterial disease. J Endovasc Ther 13 suppl 2 (2006) II3-II9
4. Rissanen T.T., Vajanto I., and Yla-Herttuala S. Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb-on the way to the clinic. Eur J Clin Invest 31 (2001) 651-666
5. Ji J.W., Mac Gabhann F., and Popel A.S. Skeletal Muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am J Physiol Heart Circ Physiol 293 (2007) H3740-H3749
6. Waters R.E., Terjung R.L., Peters K.G., and Annex B.H. Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. J Appl Physiol 97 (2004) 773-780
7. Taniyama Y., Morishita R., Hiraoka K., Aoki M., Nakagami H., Yamasaki K., et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104 (2001) 2344-2350
8. Montesinos M.C., Gadangi P., Longaker M., Sung J., Levine J., Nilsen D., et al. Wound healing is accelerated by agonists of adenosine A2 (G alpha s- linked) receptors. J Exp Med 186 (1997) 1615-1620
9. Khoa N.D., Montesinos C.M., Williams A.J., Kelly M., and Cronstein B.N. Th1 cytokines regulate adenosine receptors and their downstream signalling elements in human microvascular endothelial cells. J Immunol 171 (2003) 3991-3998
10. Leibovich S., Chen J.F., Belem P., Elson G., Rosania A., Ramanathan M., et al. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in murine macrophages by adenosine A2A receptor agonists and endotoxin. Am J Pathol 160 (2002) 2231-2244
11. Galeano M., Bitto A., Altavilla D., Minutoli L., Polito F., Calo' M., et al. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Rep Reg 16 (2008) 208-217
12. Bitto A., Galeano M., Squadrito F., Minutoli L., Polito F., Dye J.F., et al. Polydeoxyribonucleotide improves angiogenesis and wound healing in experimental thermal injury. Crit Care Med 36 (2008) 1594-1602
13. Bianchini P., Tellini N., Morani A.M., and Follano M.G. Pharmacological data on polydeoxyribonucleotide of human placenta. Int J Tissue Reac 3 (1981) 151-154
14. Chalothorn D., Zhang H., Clayton J.A., Thomas S.A., and Faber J.E. Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia. Am J Physiol Heart Circ Physiol 289 (2005) H947-H959
15. Benoit P.W., Yagiela J.A., and Fort N.F. Pharmacological correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicol Appl Pharmacol 52 (1980) 187-198
16. Novo S., Coppola G., and Milio G. Critical limb ischemia: definition and natural history. Curr Drug Targets Cardiovasc Haematol Disord 4 (2004) 219-225
17. Jones W.S., and Annex B.H. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Curr Opin Cardiol 22 (2007) 458-463
18. Kusumanto Y.H., van Weel V., Mulder N.H., Smit A.J., van den Dungen J.J., Hooymans J.M., et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 17 (2006) 683-691
19. Makino H., Ogihara T., and Morishita R. Gene therapy for peripheral arterial diseases. Nippon Rinsho 63 (2005) 491-497
20. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
21. Adair T.H. Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 289 (2005) R283-R296
22. Feoktistov I., Ryzhov S., Zhong H., Goldstein A.E., Matafonov A., Zeng D., et al. Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 44 (2004) 649-654
23. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41 (2001) 775-787
24. Fredholm B.B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14 (2007) 1315-1323
25. Lukashev D., Ohta A., and Sitkovsky M. Targeting hypoxia-A(2A) adenosine receptor-mediated mechanisms of tissue protection. Drug Discov Today 9 (2004) 403-409
26. Fredholm B.B. Adenosine receptors as targets for drug development. Drug News Perspect 16 (2003) 283-289
27. O'Regan M. Adenosine and the regulation of cerebral blood flow. Neurol Res 27 (2005) 175-181
28. Seale T.W., Abla K.A., Shamim M.T., Carney J.M., and Daly J.W. 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci 43 (1988) 1671-1684